Caroline Litchfield

Insider Reports History

Entity
Individual
Location
2000 Galloping Hill Rd, Kenilworth, NJ
Signature
/s/ Kelly E. W. Grez as attorney-in-fact for Caroline Litchfield
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caroline Litchfield:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merck & Co., Inc. EVP & CFO Common Stock 50.9K $6.39M $125.50 Apr 30, 2024 Direct
Merck & Co., Inc. EVP & CFO Stock Option (Right to Buy) 49.8K Apr 30, 2024 Direct
Merck & Co., Inc. EVP & CFO Restricted Stock Unit 0 May 1, 2023 Direct

Insider Reports Filed by Caroline Litchfield

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRK Merck & Co., Inc. Apr 30, 2024 1 $0 4 May 2, 2024 EVP & CFO
MRK Merck & Co., Inc. Feb 14, 2024 3 -$2.58M 4 Feb 15, 2024 EVP & CFO
MRK Merck & Co., Inc. Jan 22, 2024 1 $2.29M 4 Jan 24, 2024 EVP & CFO
MRK Merck & Co., Inc. May 2, 2023 1 $0 4 May 4, 2023 EVP & CFO
MRK Merck & Co., Inc. May 1, 2023 3 $50.7K 4 May 3, 2023 EVP & CFO
MRK Merck & Co., Inc. Jan 23, 2023 1 $292K 4 Jan 25, 2023 EVP & CFO
MRK Merck & Co., Inc. May 3, 2022 1 $0 4 May 5, 2022 EVP & CFO
MRK Merck & Co., Inc. May 3, 2022 3 $35.1K 4 May 4, 2022 EVP & CFO
MRK Merck & Co., Inc. May 1, 2022 3 $38.9K 4 May 3, 2022 EVP & CFO
MRK Merck & Co., Inc. Feb 24, 2022 1 $179K 4 Feb 28, 2022 EVP & CFO
MRK Merck & Co., Inc. Nov 4, 2021 3 -$1.67M 4 Nov 5, 2021 EVP & CFO
OGN Organon & Co. May 7, 2021 0 $0 3 May 7, 2021 Director